Proactive’s Post

View organization page for Proactive, graphic

22,026 followers

Genetron Holdings Limited(Genetron Health) has announced it will go private through an acquisition by a group of investors led by its co-founder and CEO Sizhen Wang and CICC Healthcare Investment Fund which values the Chinese precision oncology platform at $126 million. The company’s US-listed American Depository Shares (ADSs) jumped 27% in early Thursday trading to $1.1950. Under the terms of the deal, holders of the company’s ADSs will receive $1.36 in cash per ADS, a 42% premium to the closing price on October 10. The merger is expected to close during the first quarter of 2024, subject to conditions including the approval of shareholders holding two-thirds of its shares. The company said members of the consortium and rollover shareholders represent roughly 59.7% of its shares. Genetron specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development. Contact the author at... More at #Proactive #ProactiveInvestors http://ow.ly/vG67104XzuP

Genetron stock rallies on CEO-led deal to go private

Genetron stock rallies on CEO-led deal to go private

proactiveinvestors.com

To view or add a comment, sign in

Explore topics